Top 5 Biotech Startup Investors in Luxembourg in January 2026
A list of 5 angel investors and VC (Venture Capital) funds that invest in Biotech startups based in Luxembourg. We rank investors based on the number of investments they made in Biotech companies from Luxembourg. We update this investor list every month.Top 5 Biotech Startup Investors in Luxembourg in January 2026
| Investor | Biotech Luxembourg investments |
|---|---|
| Expon Capital | 2 |
| Atlantic Bridge | 1 |
| Be Angels | 1 |
| Expansion Ventures | 1 |
| KHAN Technology Transfer Fund | 1 |
Global investor in big ideas with the potential for positive impact & exponential growth
Show more
Investment focus
- Software, E-Commerce, Financial Services
- Seed, Series A, Series B
- Luxembourg, France, United States
Portfolio highlights
- ClimateCamp — Looking for a sustainable way to collaborate with your suppliers on emissions reduction projects? Look no further than our platform - Book a demo for free!
- Invitrolize — Our human in vitro model allows for the first time the identification and differentiation of respiratory sensitizers and respiratory irritants under air-liquid interphase realistic exposure conditions.
- Exobiosphere — Exobiosphere is a cutting-edge company operating at the intersection of space exploration and biotechnology.
Atlantic Bridge is a Growth Equity Firm with a Cross Border Value Add strategy. We invest in deep technology companies in Europe and the US. Our team is made up of successful entrepreneurs and senior technology industry executives and we invest in strong ambitious entrepreneurs and management teams that have the passion and drive to scale up andexploit major growth opportunities. We help our portfolio companies expand and grow internationally through our global platform with our team and offices in London, Dublin, Munich, Paris and Palo Alto.Atlantic Bridge brings together a unique team of technology entrepreneurs, experienced managers, finance professionals, and investment experts. The team contains a wealth of international business experience across Europe, the UK and the US. They have worked together in various capacities for the last 30 years, bringing a true partnership approach to their firm and their investments. Its investors include the founders, leading institutional investors, and private investors with a track record of investment in successful technology companies.Atlantic Bridge has developed a unique and differentiated strategy that focuses on specific technology themes and the implementation of the “Atlantic Bridge Model” for scaling companies internationally. The “Bridge Model” accelerates the scale-up of technology companies in Europe and the US. This approach is highly differentiated and has delivered strong performance results to date.
Show more
Investment focus
- Software, Artificial Intelligence, Analytics
- Series A, Series B, Funding Round
- United States, Ireland, United Kingdom
Portfolio highlights
- SOC Prime — SOC Prime is the only Threat Detection Marketplace where researchers monetize their content to help security teams defend against attacks faster and more efficiently than ever. Powered by its Detection as Code platform, SOC Prime curates the most up-to-date Sigma-based threat detection content from over 300 researchers and natively delivers it viasubscription to 20+ SIEM and XDR platforms at more than 6,000 enterprises, governments and MDRs worldwide.
- Insight Terra — Insight Terra supports data driven risk management in critical situations where business operations, people and the environment all come together.
- Output Sports — Discover Output's portable and affordable athlete testing and tracking device. Measure strength, power and speed in minutes giving accurate and reliable data.
Early stage Entrepreneurs Coaching and FinancingOne of Europe's leading Business Angels Networks. We connect innovative growth companies to equity finance and coaching by experienced angel investors.
The network is 250 members strong and has been assisting innovative entrepreneurs to find financing for more than 10 millions Euros in thelast 4 years.
Show more
Investment focus
- Software, Information Technology, SaaS
- Seed, Pre-Seed, Funding Round
- Belgium, France, Spain
Portfolio highlights
- Savics — Savics offers digital solutions for health actors to improve their data management, disease diagnostics and GeneXpert connectivity.
- DeftHedge — DeftHedge is an application addressed to business leaders, and CFOs facing volatility of foreign exchange market.
- NIUM — NIUM is a startup focused on personalized nutrition and gut microbiome research. NIUM created science-based solutions to transform nutrition research and product development.
Expansion is an venture fund to support European Aerospace & Defence startups.
Show more
Investment focus
- Aerospace, Space Travel, Cyber Security
- Seed, Series B
- France, Spain
Portfolio highlights
- ION-X — Based on patented technology, our unique ionic liquid electrospray thrusters is the next big thing in small satellites propulsion.
- U-Space — U-Space Nanosatellites specializes in the design and manufacturing of next-generation nanosatellites tailored for a variety of applications including commercial services, scientific missions, and defense projects. With a focus on innovation, U-Space offers turnkey solutions encompassing a range of nanosatellite sizes such as 3U, 6U, and 12Uconfigurations. The company is dedicated to transforming client needs into high-performance space systems, marking significant milestones in the space industry with projects like the launch of NESS. U-Space collaborates with partners for components supply, contributing to the development of the French space sector and aiming to lead in nanosatellite constellations by 2025.
- UNIVITY — We envision bringing high speed / low latency connectivity anywhere in the world.
KHAN Technology Transfer Fund operates as an investment firm.
Show more
Investment focus
- Medical, Biotechnology, Pharmaceutical
- Seed, Series A, Funding Round
- Germany, Luxembourg, Czech Republic
Portfolio highlights
- Nodus Oncology — Nodus Oncology Developing the DDR targeting therapies.
- Casinvent Pharma — Casinvent Pharma develops new therapeutic options for the treatment of selected malignancies.
- OrganoTherapeutics — Human iPSC-derived Midbrain Organoids. Advanced brain organoid and assembloid models. Research on Parkinson's Disease. Drug and therapeutics research. High-throughput and AI-driven algorithms for organoid data analysis.
Investors by industry
Community
Artificial intelligence
Hardware
Marketplace
Consumer
FinTech
Energy
Gaming
Impact
Climate
Proptech
Google
Biotech
EdTech
Sustainability
Health Care
Venture Capital
Clean Energy
Art
Web3
Organic Food
Big Data
Video Games
Wellness
Publishing
B2B
Android
Food and Beverage
Payments
Real Estate
Finance
Education
Financial Services
Digital Media
Retail
Infrastructure
Beauty
Manufacturing
Photography
Biotechnology
Travel
Fitness
Recruiting
Construction
Hospitality
Mobile Advertising
Platforms
Cannabis
Sports
Automotive
Social
Wine And Spirits
Medical Device
Franchise
Crowdfunding
CleanTech
eSports
Mobile Apps
Transportation
InsurTech
Enterprise
Mobile
Enterprise Software
Music
LGBT
Email
Social Media
Social Network
Medical
Legal
Local
Internet
Oil and Gas
Fashion
Non Profit
Film
Life Science
Theatre
SaaS
Renewable Energy
Sporting Goods
Restaurants
Software
Celebrity
Social Impact
Facebook
Cryptocurrency
Machine Learning
Agriculture (agtech)
Media (entertainment)
Blockchain
Investors by country
New Zealand
Ireland
Canada
United States
India
Germany
United Kingdom
South Korea
Australia
Middle East
Indonesia
South Africa
Sri Lanka
Vietnam
Europe
Qatar
Japan
Singapore
Ghana
Spain
Egypt
Belarus
Hungary
China
Finland
Armenia
France
Croatia
Saudi Arabia
Gibraltar
Barbados
Georgia
Greece
Oceania
Czech Republic
Faroe Islands
Costa Rica
Africa
Hong Kong
Bahrain
Belgium
LATAM
Denmark
Bermuda
Asia
Estonia
Algeria
Ecuador
Brazil
Bulgaria
Belize
Chile
Liechtenstein
Ethiopia
Togo
Rwanda
Slovenia
Poland
Panama
Uganda
San Marino
Sweden
Serbia
Sierra Leone
Thailand
Tanzania
Uzbekistan
Zambia
Turkey
Uruguay
Tajikistan
Russian Federation
Portugal
Myanmar
El Salvador
Puerto Rico
Senegal
Lithuania
Zimbabwe
Tunisia
Venezuela
Ukraine
Taiwan
Dominican Republic
Malaysia
Bahamas
Iraq
Iceland
Azerbaijan
Nigeria
Namibia
United Arab Emirates
Jamaica
Honduras
Peru
Isle of Man
Bolivia
Luxembourg
Liberia
Pakistan
Jersey
Albania
Lebanon
Norway
Romania
Mexico
Jordan
Grenada
Argentina
Bangladesh
Italy
Mali
Philippines
Israel
Kuwait
Mauritius
Malta
Morocco
Nicaragua
Kazakhstan
Kenya
Cayman Islands
Cambodia
Cyprus
Oman
Latvia
Cameroon
Austria
Switzerland
Colombia
Guatemala
Seychelles
Marshall Islands
Investors in Luxembourg by industry
Travel
Finance
Social Media
Manufacturing
Mobile
Blockchain
Financial Services
FinTech
Payments
Enterprise
Consumer
Health Care
Climate
Energy
Sustainability
Impact
SaaS
Proptech
Marketplace
Artificial intelligence
Community
Hardware
B2B
Web3
Gaming
Real Estate
Software
Internet
Video Games
Media (entertainment)
Transportation
Social Network
Biotechnology
InsurTech
Biotech